Company intelligence / Profile preview
DTC Biotech
Shenzhen, Guangdong, Chinadtcbiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
DTC Biotech is a clinical-stage biotechnology company based in Shenzhen, China, specializing in the development of next-generation cell therapies and mRNA-based therapeutics. The company focuses on leveraging its proprietary DTC-CAR-T platform to create highly efficient and safer treatments for hematological malignancies, solid tumors, and autoimmune diseases. Their pipeline includes several CAR-T candidates targeting CD19 and BCMA, with a particular emphasis on optimizing cell persistence and reducing toxicity. DTC Biotech also explores mRNA technology and lipid nanoparticle (LNP) delivery systems to expand its therapeutic reach into vaccines and protein replacement therapies.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Cell therapyCAR-T cell therapymRNA-based drugsLipid nanoparticle delivery therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on DTC Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DTC Biotech.